$12 does not do what we have lined up any justice. I am legitimately waiting for $20+, in which I am very confident we will get. If we are going to already start knocking on $6 as shown by that chart, once FDA approves trof, NEU will then apply for other indications including Autism. Our other pipeline drugs currently in development with one of them looking even more promising than trofinitide, we have a very bright future to look forward to.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$13.91 |
Change
0.600(4.51%) |
Mkt cap ! $1.668B | |||
| Open | High | Low | Value | Volume |
| $13.50 | $13.94 | $12.96 | $2.942M | 217.8K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 8 | 137 | $13.90 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $13.92 | 632 | 2 |
View Market Depth
| Last trade - 11.31am 27/06/2025 (20 minute delay) ? |
| NEU (ASX) Chart |